Cited by 8Ear and Head TumorsErythropoietin and Anemia TreatmentMyeloproliferative Neoplasms: Diagnosis and Treatment

Erythrocytosis and the Chuvash von Hippel-Lindau mutation

Open access
Percy, Melanie J., Beard, Michael E. J., Carter, Chris, Thein, Swee Lay·2003·British Journal of Haematology

Abstract

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2141.2003.04631.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. Halsey, C. & Roberts, I.A.G. (2003) The role of hydroxyurea in sickle cell disease. British Journal of Haematology, 120, 177-186.
  2. Stricker, R.B., Linker, C.A., Crowley, T.J. & Embury, S.H. (1986) Hematology malignancy in sickle cell disease: report of four cases and review of the literature. American Journal of Hematology, 21, 223-230.
  3. Wilson, S. (2000) Acute leukemia in a patient with sickle cell an- emia treated with hydroxyurea. Annals of Internal Medicine, 133, 925-926.
  4. Azzara `, A., Carulli, G., Polidori, R., Ceccarelli, M., Simoni, F. & Ambrogi, F. (1988) In vitro restoration by lithium of defective chemotaxis in Shwachman-Diamond syndrome. British Journal of Haematology, 70, 502.
  5. Azzara `, A., Chimenti, M., Azzarelli, L., Fantini, E., Carulli, G. & Ambrogi, F. (1992) An image processing workstation for auto- matic evaluation of human granulocyte motility. Journal of Immunological Methods, 148, 29-40.
  6. Azzara `, A., Chimenti, M., Carulli, G., Rizzuti-Gullaci, A. & Ambrogi. F. (1995) An image processing procedure for the assessment of normality curves of motility of human granulocytes in micropore filters. Scandinavian Journal of Clinical and Laboratory Investigation, 55, 399-408.
  7. Dror, Y. (2002) Shwachman-Diamond syndrome. British Journal of Haematology, 118, 701-713.
  8. Holada, K. & Vostal, J.G. (2000) Different levels of prion protein (PrPC) expression on hamster, mouse and human blood cells. British Journal of Haematology, 110, 472-480.
  9. Sivakumaran, M. (2003) The expression of prion protein (PrPc) by endothelial cells: an in vitro culture-induced artefactual phe- nomenon? British Journal of Haematology, 121, 673-674.
  10. Starke, R., Drummond, O., MacGregor, I., Biggerstaff, J., Gale, R., Camilleri, R., Mackie, I., Machin, S. & Harrison, P. (2002) The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? British Journal of Haematology, 119, 863-873.
  11. Fabrizio, M.C. (2002) Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass. Journal of Extracorporeal Technology, 33, 117-125.
  12. Moser, M., Ruef, J., Peter, K., Kohler, B., Gulba, D.C., Paterna, N., Nordt, T., Kubler, W. & Bode, C. (2001) Ecarin clotting time but not aPTT correlates with PEG-Hirudin plasma activity. Journal of Thrombosis and Thrombolysis, 12, 165-169.
  13. Saad, R.A., Horn, I. & Mankad, P.S. (2002) Management dilemma of cardiopulmonary bypass in patients with type II heparin in- duced thrombocytopenia. British Journal of Haematology, 119, 880.
  14. Warkentin, T.E. (2003) Heparin-induced thrombocytopenia: path- ogenesis and management. British Journal of Haematology, 121, 535-555. Keywords: heparin-induced thrombocytopenia, recombin- ant hirudin, anticoagulant therapy, ecarin clotting time. REFERENCES
  15. Greinacher, A. (2001) Recombinant hirudin for the treatment of heparin-induced thrombocytopenia. In: Heparin-induced Thromb- ocytopenia 2nd edn (ed. by T.E. Warkentin & A. Greinacher), pp. 349-380.
  16. Warkentin, T.E. & Greinacher, A. (2003) Heparin-induced thrombocytopenia and cardiac surgery. Annals of Thoracic Sur- gery, in press.

Cited by

Sorted by citations

Authors
Percy, M. J., Beard, M. E. J., Carter, C., & Thein, S. L.
Affiliations
  • Belfast City Hospital (GB)
  • Christchurch Hospital (NZ)
  • Huddersfield Royal Infirmary (GB)
  • King's College Hospital (GB)
Venue
British Journal of Haematology
Publisher
Wiley
Published
2003-10
Volume
123
Issue
2
Pages
371-372
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1998160968
Cited by
8
References
5
Citations by year
2018: 1 · 2013: 2
FWCI
0.30
Type
journal article
Language
en
Open access
Locations
  • British Journal of Haematology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Ear and Head Tumors
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Genetics › Myeloproliferative Neoplasms: Diagnosis and Treatment
Keywords
erythrocytosis, von Hippel-Lindau disease, VHL mutation, Chuvash people, hereditary erythrocytosis, somatic mutations
MeSH terms
Female, Follow-Up Studies, Humans, Infant, Ligases, Mutation, Polycythemia, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review